Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression
Authors:
- 13 September 2023
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 231, 173637
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81873734, 81974200)
This publication has 49 references indexed in Scilit:
- Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740Neuroscience, 2013
- Regulation of NMDA receptors by the tyrosine kinase FynThe FEBS Journal, 2011
- Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulataNeuroscience Letters, 2011
- Factors related to functional independence in females with Parkinson's disease: A systematic reviewMaturitas, 2011
- Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian ratsExperimental Neurology, 2011
- Striatal Overexpression of ΔFosB Reproduces Chronic Levodopa-Induced Involuntary MovementsJournal of Neuroscience, 2010
- Pharmacological Modulation of Glutamate Transmission in a Rat Model of l-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear SignalingThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Regulation of NMDA receptors by phosphorylationNeuropharmacology, 2007
- Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced DyskinesiaThe Journal of Neuroscience, 2007
- Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's DiseaseNeurobiology of Disease, 1999